Fatigue News and Research

RSS

Self-care can help nurses manage compassion fatigue

The heart of healthcare is stressed. With longer shifts, staffing shortages and healthcare changes taxing our nurses, it's no surprise that up to 80 percent report suffering compassion fatigue at some point in their careers, according to recent studies.

26 May 2016

Researchers find potential link between pulmonary function and vocal fatigue symptoms in women

Teaching is an occupation with a high risk of developing vocal problems -- teachers have more than twice the voice problems than people in other professions, as the voice is the major tool in classroom instruction and is often used for long periods of time and in noisy environments.

26 May 2016

Shoulder, arm pain could stem from thoracic outlet syndrome

Shoulder and arm pain come with the territory for some athletes and certain occupations like hair stylists, mechanics, even office workers.

26 May 2016

The National MDS Study aims to identify causes, genetic makeup of fatal blood diseases

The National Myelodysplastic Syndromes Natural History Study is underway, the ECOG-ACRIN Cancer Research Group and its collaborators announced today.

26 May 2016

AF-related symptoms and quality of life worse in women

Women with atrial fibrillation experience more severe symptoms, a lower quality of life and a higher risk of stroke than men, but they have better overall survival, US study data show.

24 May 2016

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Chatting on the phone with a "sleep coach" and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine.

24 May 2016

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial.

23 May 2016

Tecentriq drug gets FDA approval to treat urothelial carcinoma

The U.S. Food and Drug Administration today approved Tecentriq (atezolizumab) to treat the most common type of bladder cancer, called urothelial carcinoma. This is the first product in its class (PD-1/PD-L1 inhibitors) approved to treat this type of cancer.

19 May 2016

Wyss Institute partners with ReWalk to accelerate development of wearable, soft exosuits

The Wyss Institute for Biologically Inspired Engineering at Harvard University has entered into a collaboration with ReWalk Robotics Ltd., to accelerate the development of the Institute's lightweight, wearable soft exosuit technologies for assisting people with lower limb disabilities.

18 May 2016

Study finds greater activation of biological fight or flight mechanism in chronic fatigue syndrome patients

Chronic fatigue syndrome patients report they are more anxious and distressed than people who don't have the condition, and they are also more likely to suppress those emotions.

18 May 2016

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

AbbVie, a global biopharmaceutical company, today announced The Lancet Oncology published results from the Phase 2, single arm, open label trial studying venetoclax in patients with relapsed/refractory (R/R) chronic lymphocytic leukaemia (CLL) with 17p deletion.

17 May 2016

Experimental hepatitis C drug slows down development of Zika in mice

Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy.

17 May 2016

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. has received approval from the U.S. Food and Drug Administration (FDA) for an additional indication for Eisai's in-house developed novel anticancer agent Lenvima (lenvatinib mesylate) in combination with everolimus for the treatment of patients with advanced renal cell carcinoma following one prior anti-angiogenic therapy.

16 May 2016

Pluristem completes enrollment in Phase II intermittent claudication trial

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.

16 May 2016

New national survey reveals that asthma patients most frequently use rescue inhaler

In a new national survey of asthma patients, Health Union, and its new online community Asthma.net, reveals that most were satisfied with the care they received; however, the most frequently used form of treatment, at 89%, is the rescue inhaler.

12 May 2016

Thermo Scientific Niton XL5 analyzer can provide results rapidly and with high accuracy

Managers, operators and quality control personnel in the oil and gas, power generation, automotive, aerospace and metal recycling industries can now assess the chemical composition of metals with a new analyzer that is smaller and lighter than any X-ray fluorescence (XRF) alloy analyzer on the market today.

From Thermo Fisher Scientific Inc. 12 May 2016

Fatigue News and Research

Self-care can help nurses manage compassion fatigue

Researchers find potential link between pulmonary function and vocal fatigue symptoms in women

Shoulder, arm pain could stem from thoracic outlet syndrome

The National MDS Study aims to identify causes, genetic makeup of fatal blood diseases

AF-related symptoms and quality of life worse in women

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Tecentriq drug gets FDA approval to treat urothelial carcinoma

Wyss Institute partners with ReWalk to accelerate development of wearable, soft exosuits

Study finds greater activation of biological fight or flight mechanism in chronic fatigue syndrome patients

Phase 2 results of AbbVie’s venetoclax in patients with R/R CLL with 17p deletion published in The Lancet Oncology

Experimental hepatitis C drug slows down development of Zika in mice

FDA approves additional indication for Eisai's anticancer agent Lenvima in combo with Everolimus for advanced renal cell carcinoma

Pluristem completes enrollment in Phase II intermittent claudication trial

New national survey reveals that asthma patients most frequently use rescue inhaler

Thermo Scientific Niton XL5 analyzer can provide results rapidly and with high accuracy

Griffith researchers closer to identifying cause of Chronic Fatigue Syndrome

Sheffield Hallam University lecturer to discuss research into cause of fibromyalgia at parliamentary event

Innovative inflatable footbaths can help you nod off easily during hot sticky nights

Study shows risk of developing MDD depends on symptom centrality in network

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News